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Abstract
Background: Human Plexin-B1 is expressed in two truncated forms. The long form encodes a
trans-membranal protein, while the short form, which is bound to the cell surface and partially
secreted, possibly serves as a decoy receptor. Plexin receptors are trans-membrane proteins. The
sema domain, found in the extracellular region, is common to all plexins, semaphorins, and the
scatter factor receptors and is crucial for the biological activity and plexin receptor specificity.
Semaphorin-4D/Plexin-B1 binding provides attractive and repulsive cues for the navigation of
axonal growth cones, and new studies suggest that this system also plays a role in the regulation of
the biological functions of endothelial cells, specifically in the control of angiogenesis. In a previous
study, we have demonstrated the expression and possible role of Plexin-B1 in the mouse ovary.
The present study was designed to test the hypothesis that Plexin-B1 effects are mediated by
Semaphorin-4D.
Methods:  In vivo expression and localization of mouse ovarian Sema-4D were tested by
immunohisto-chemistry. The role of Sema-4D in follicular development was examined by in vitro
growth of preantral follicles in the presence or absence of Semaphorin-4D, with or without
neutralizing antibodies against Plexin-B1. Follicular growth and steroid hormone secretion rates
were tested.
Results: Semaphorin-4D is expressed in the mouse ovary in vivo mostly in the granulosa cells and
and its expression is modulated by PMSG and hCG. In the presence of Semaphorin-4D, in-vitro
constant growth was observed as indicated by follicular diameter during the culture period and
elevated steroid hormone secretion rates compared with control. These effects were abolished
after addition of neutralizing antibodies against Plexin-B1.
Conclusion: In the ovarian follicle, the effect of Plexin-B1 is mediated by sema-4D.
Background
Semaphorins and Plexins are independently identified
protein families that share a striking structural similarity
and are believed to derive from a common ancestor [1].
Semaphorins were originally characterized in the nervous
system, where they have been implicated in repulsive
axon guidance [2].
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The class 4 Semaphorin (Sema-4D), through binding of
its receptor, Plexin-B1, exerts important biological effects
on a variety of cells. A significant role for these molecules
has been established in cardiac and skeletal development
[3], immune response [4], epithelial morphogenesis [5]
and tumor growth and metastasis [6].
Plexin-B1 is highly expressed in endothelial cells (EC) and
its activation by Sema-4D elicits a potent pro-angiogenic
response and induces EC migration [7]. Sema-4D/Plexin-
B1 binding sustains proliferation and survival of normal
and leukemic CD5+ B lymphocytes [8].
Plexin activation hinders cell attachment to adhesive sub-
strates, blocks the extension of lamellipodia, and thereby
inhibits cell migration [9].
Plexin activation in adhering cells rapidly leads to retrac-
tion of cellular processes and cell rounding (cell collapse)
[10].
Sema-4D is able to activate the invasive growth program
in epithelial cells, a complex process including dissocia-
tion of cell-to-cell adhesive contacts, anchorage-inde-
pendent growth, and branching morphogenesis [5].
The plexin-semaphorin system is implicated in cyto-skel-
etal re-organization, adhesion and cell proliferation. All
these functions are utilized during the process of follicular
development during the estrus cycle. The growing follicle
must reshape by creating an antrum and at least two cell
populations. The follicle also must expand and proliferate
in order to grow into mature graafian follicle. We hypoth-
esize that the effect of Plexin-B1 in the ovarian follicle is
mediated by sema-4D. The present study was designed to
test this hypothesis.
Methods
Animals
All experiments were conducted using female ICR mice
(Harlan, Israel), housed and bred in a temperature- and
light-controlled room, and provided food and water. The
study was approved by the local ethics committee
(840201).
(a) – Thirty female mice, 26 days old, were injected with
5 IU pregnant mare serum gonadotropin (PMSG). Ten
mice were sacrificed 48 hours following injection. The
remaining 20 mice were injected with 5 IU human chori-
onic gonadotropin (hCG), 24 hours after PMSG injection.
Ten were sacrificed 6 hours following injection and the
last 10 were sacrificed 24 hours following injection. A
group of 10 immature female mice that were not treated
served as control for untreated mice. The ovaries were
fixed in 4% formalin and embedded in paraffin for immu-
nohistochemistry analysis
(b) – Preantral follicles were collected from sixteen, 12-
day-old, female ICR mice by ovarian micro-dissection.
Isolation of preantral follicles
Ovaries from 12-day old ICR mice were removed asepti-
cally, separated from the connective tissue, and placed in
2.5 mL of M-199 supplemented with 5% fetal calf serum
(FCS), 100 mIU/mL penicillin, and 100 mg/mL strepto-
mycin (all from Biological Industries, Beit-Ha'Emek,
Israel) at 37°C. For each mouse, ovaries were dissected
mechanically using a 26-gauge needle in M-199 medium
supplemented with 5% FCS.
Culture of preantral follicles
Isolated follicles were rinsed three times in 30 μL of cul-
ture medium composed of M-199 medium supplemented
with 100 mIU/mL FSH and 100 mIU/mL LH (Pergonal,
Serono laboratories), 5% FCS [11] in the absence or pres-
ence of Sema-4D (50 ng/ml) kindly donated by L. Tama-
gnone [5] (Institute for Cancer Research and Treatment,
University of Turin Medical School, Turin, Italy) with and
without 200 ng/mL neutralizing antibodies against
Plexin-B1 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). An intact preantral follicle was defined as a round
follicular structure containing a visible oocyte centrally
located and surrounded by more than one granulosa cell
layer (generally two layers) with at least one completed
granulosa cell layer. Follicles were measured under 100×
magnification with a pre-calibrated ocular micrometer. A
total of 151 Follicles of 100–130 μm were selected and
individually cultured for 12 days in 24-well Falcon culture
dishes (Becton Dickinson, Le Pont de Claix, France) using
35 μL of culture medium under 0.6 mL of mineral oil
(Sigma Aldrich, St. Louis, MO) at 37°C in a humidified
atmosphere of 5% CO2 in air. On days 3, 4, 5, 8, 9, 10, 11
and 12 of the culture period, 10 μL of culture medium
from each drop was collected and frozen for subsequent
hormonal assay. After 9 days of culture, 1.5 IU/mL
Human chorionic gonadotropin (hCG) (Ares Serono,
Geneva, Switzerland) was added to the culture medium to
induce follicular rupture [12].
Hormonal measurements
In five independent experiments, conditioned media
from surviving follicles were collected at different times of
culture. Surviving follicles were defined as the attached
follicles that had retained their oocytes in the granulosa
cell mass. Media were frozen and hormonal measure-
ments were performed at the end of each experiment.
Estradiol (E2), Progesterone (P4), and Testosterone (T)
were measured using EIA commercial kits (cat. nos. RE-
522-31, RE-520-41, and RE-521-51, respectively;Reproductive Biology and Endocrinology 2007, 5:12 http://www.rbej.com/content/5/1/12
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Immuno-Biological Laboratories, Inc., Minneapolis, MN)
according to the manufacturer's recommendations.
Immunohistochemistry
All specimens taken from the untreated and PMSG, hCG
treated 26-day old mice were fixed in 4% formalin and
embedded in paraffin. For immuno-histochemical stain-
ing, the endogenous peroxidase in formalin-fixed paraf-
fin-embedded tissue was inhibited by incubating
specimens with 0.5% H2O2 for 10 minutes before incuba-
tion with the primary rabbit polyclonal IgG anti- Sema-
4D (Santa cruz, sc-20928). The slides were incubated with
anti-Sema-4D primary antibodies at a 1:100 dilution, and
developed using the streptavidin-biotin system according
to the manufacturer's instructions. Sema-4D was identi-
fied as brown membrane staining in ovarian sections
counterstained with hematoxylin. Tissue used as positive
control in this study was obtained from the spinal cord
(data not shown). Negative controls were run routinely in
parallel by replacing the primary antibody with rabbit IgG
antibody. No specific immuno-reactivity was detected in
these negative control specimen tissues.
The immunohistochemistry photos were analyzed by
Image Pro software that quantifies density per area. At
least 3 sections from each ovary were evaluated.
Statistics
Each independent experiment was repeated at least 3
times. All data are presented as mean ± SEM. Statistical
analysis of the data was carried out with one-way analysis
of variance (ANOVA). t-tests were used to compare
between two groups as post ANOVA test; P < 0.05 was
considered significant.
Results
In vivo Semaphorin-4D expression
Immunohistochemistry of ovaries obtained from 26-day
old untreated and treated mice revealed staining for Sema-
4D, mainly in the periluminal granulosa cells, at all stages
(Figure 1). Sema-4D staining increased after PMSG or
hCG injection (P < 0.0016). Sema 4D was also observed
in the follicular lumen six hours following hCG injection.
In the control group, representing non-stimulated folli-
cles, low levels of Sema 4D were observed (Figure 1).
The effect of Sema-4D on in vitro follicular growth and 
development
In vitro cultures of preantral mouse follicles, obtained
from 12-day old ICR female mice, were cultured for 12
days in medium (control, n = 29), medium containing
Sema-4D alone (50 ng/ml, n = 34) and medium contain-
ing Sema-4D and neutralizing antibodies against Plexin-
B1 (200 ng/mL, n = 34). On day 9, hCG was added to the
culture. Follicular growth and development were esti-
mated by measuring follicular diameters, using a micro-
scope scale, and represented as mean ± SEM.
A significant increase in follicular diameter during the cul-
ture period was observed in the control group (P < 0.05).
A statistically significant difference was found between
follicular diameter on day 1 of the culture period (mean
primary follicular diameter) and follicular diameter on
day 11 of the culture period (mean maximal follicular
diameter). The mean diameter was 100.65 ± 0.28 versus
190.93 ± 3.32, respectively (P < 0.05; Figure 2).
A significant increase in follicular diameter during the cul-
ture period was also observed in the Sema-4D treated
group (P < 0.05; Figure 2). Comparison of the mean fol-
licular diameter, between day 1 (mean primary follicular
diameter) and day 9 of the culture period (mean maximal
follicular diameter) in the control group revealed a signif-
icant difference between the two groups (the mean diam-
eter was 100.55 ± 0.24 versus 210.42 ± 0.24, respectively,
P < 0.05). Comparison of the maximal follicular diameter
between the control and Sema-4D treated group revealed
no significant difference, (190.93 μm ± 3.32 and 210.42
μm ± 0.24 respectively; Figure 2). However, the period of
time needed to reach this diameter in the Sema-4D treated
group was significantly shorter compared with the control
group (day 9 ± 0.28 versus day 11 ± 0.0001: P < 0.03; Fig-
ure 2).
The addition of neutralizing antibodies against Plexin-B1
to the follicles treated with sema-4D abolished the effect
of sema-4D on follicular growth (P < 0.005; Figure 2).
Comparison of the mean follicular diameter, between day
1 (mean primary follicular diameter) and day 8 (mean
maximal follicular diameter) in the control group,
revealed no significant differences (Day 1 90.73 ± 0.06
versus Day 8 130.27 ± 1.13).
However, maximal follicular diameter in the Sema-4D
group (day 9 of culture period) was significantly higher
than in the group treated with Sema-4D and neutralizing
antibodies against Plexin-B1 (day 8 of culture period)
(210.42 μm ± 0.24 and 130.27 μm ± 1.13, respectively, p
< 0.005; Figure 2)
The effect of Sema-4D on steroidogenesis
Conditioned media from control follicles (n = 18), folli-
cles treated with Sema-4D alone (50 ng/ml, n = 18), and
follicles treated with Sema-4D and neutralizing antibod-
ies against Plexin-B1 (50 ng/ml and 200 ng/mL, respec-
tively, n = 18) were analyzed for E2, P4 and T secretion on
days 3, 4, 5, 8, 9, 10, 11 and 12 of the culture period.
As illustrated in Figure 3A, the E2 secretion rate was signif-
icantly increased during the culture period in the controlReproductive Biology and Endocrinology 2007, 5:12 http://www.rbej.com/content/5/1/12
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and Sema-4D groups (P < 0.0026 and p < 0.001, respec-
tively). Comparison of E2 levels in each group during the
culture period revealed a significant difference (mean
peak E2 level in the control 46.92 ± 11.49 versus 101.41 ±
34.60 in the sema-4D group, P < 0.001). The addition of
neutralizing antibodies against Plexin-B1 (200 ng/mL)
abolished the increase seen with Sema-4D (mean peak E2
levels in the sema-4D group 101.41 ± 34.6 versus 41.06 ±
12.8 pg/ml in the presence of neutralizing antibodies
against Plexin-B1; P < 0.001).
Figure 3B illustrates the P4 secretion rate in the control and
study groups. In the control and Sema-4D groups, P4
secretion rate remained unchanged during the first days of
the culture period and increased significantly on days 10
and 12, respectively (P < 0.005.) Comparison between the
mean peak of P4 secretion level in the control versus sema-
4D group, revealed no significant change (0.24 ± 0.1 ver-
sus 0.17 ± 0.08, respectively). In the presence of neutraliz-
ing antibodies against Plexin-B1 (200 ng/mL), the P4
secretion rate remained unchanged during the culture
period.
Comparing the peak P4 levels between follicles treated
with Sema-4D and follicles treated with neutralizing anti-
bodies against Plexin-B1 revealed a significant difference
between the two groups (0.17 ± 0.08 versus 0.07 ± 0.03
ng/ml progesterone secretion; P < 0.016).
Figure 3C illustrates the T secretion rate in the control and
study groups. In all groups, the T secretion rate was not
significantly altered throughout the culture period. The
mean peak T level was of 0.12 ± 0.05 in the control group,
0.31 ± 0.26 ng/ml in the sema-4D group, and 0.12 ± 0.01
Immunohistochemical staining revealing the presence of Sema-4D in the mouse ovary at all stages: (A) un-stimulated (B) after  PMSG administration, (C) 6 hours after hCG administration, and (D) 24 hours after hCG administration Figure 1
Immunohistochemical staining revealing the presence of Sema-4D in the mouse ovary at all stages: (A) un-stimulated (B) after 
PMSG administration, (C) 6 hours after hCG administration, and (D) 24 hours after hCG administration. Sema-4D was identi-
fied as red-brown membrane staining in ovarian sections counterstained with hematoxylin; magnification ×400. Bar graph 
describing the relative percentage of Sema-4D expression, representing, mean ± SEM from three independent experiments.Reproductive Biology and Endocrinology 2007, 5:12 http://www.rbej.com/content/5/1/12
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ng/ml in the group treated with neutralizing antibodies
against Plexin-B1.
Discussion
Immunohistochemical studies revealed staining for
Sema-4D in the mouse ovary at all stages, mainly in the
peri-luminal granulosa cells. The staining became more
evident following PMSG or hCG injection. Following
hCG injection, Sema-4D was observed in the lumen.
Sema-4D is the only semaphorin for which membrane
and soluble forms are endowed with functional proper-
ties, and for which bidirectional signaling has been sug-
gested. Both human and mouse Sema 4D are cleaved and
released from the membrane as a 120 kDa soluble form
[13]. Sema-4D transcripts are observed at high levels in
both lymphoid and non-lymphoid organs including the
brain, heart, kidney, spleen, thymus, and lymph nodes
[14]. The increase in Sema-4D staining after PMSG and
hCG might suggest that it is under hormonal regulation.
However, we cannot exclude the possibility that as a result
of hormonal regulation, other changes that occur within
the follicle, i.e. growth factors secretion, might be
involved in Semaphorin-4D expression. In our previous
study we found similar patterns of expression for Plexin
B1 in the mouse ovary [15]. The finding that Plexin-B1 lig-
and, Sema 4D, is also expressed in the mouse follicle and
increases after hormonal treatment suggests follicular
auto-regulation of the Plexin/Semaphorin system.
Since there is no known Semaphorin inhibitor, the effect
of the ligand had to be studied by stimulation. In this
study, the addition of Sema-4D revealed no significant
Diameter of follicles obtained from 12-day old ICR mice and grown in in-vitro cultures for 12 days in M-199 Medium containing  gonadotropins (FSH and LH 100 mIU/ml) and with the addition of Sema-4D (50 ng/ml) in the presence or absence or of specific  neutralizing antibodies against Plexin-B1 (200 ng/ml) Figure 2
Diameter of follicles obtained from 12-day old ICR mice and grown in in-vitro cultures for 12 days in M-199 Medium containing 
gonadotropins (FSH and LH 100 mIU/ml) and with the addition of Sema-4D (50 ng/ml) in the presence or absence or of specific 
neutralizing antibodies against Plexin-B1 (200 ng/ml). On day 9 hCG was added to the culture. Blue diamond represents the fol-
licular diameter in the control group, Pink square represents the follicular diameter in the Sema-4D group. Turquoise triangle 
represents follicle diameter in the group treated with Sema-4D and neutralizing antibodies against Plexin-B1.Reproductive Biology and Endocrinology 2007, 5:12 http://www.rbej.com/content/5/1/12
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Secretion of steroid hormones (A. Estradiol; B. Progesterone and C. Testosterone), obtained from conditioned media from  cultured follicles over 12 days in the absence (Dark blue circles) or presence of Sema-4D (Pink square) or in combination with  specific neutralizing antibodies against Plexin-B1 (turquoise triangles) Figure 3
Secretion of steroid hormones (A. Estradiol; B. Progesterone and C. Testosterone), obtained from conditioned media from 
cultured follicles over 12 days in the absence (Dark blue circles) or presence of Sema-4D (Pink square) or in combination with 
specific neutralizing antibodies against Plexin-B1 (turquoise triangles). The graph represents mean ± SEM of the steroid hor-
mones secreted from three independent experiments in triplicate.
ure 3Reproductive Biology and Endocrinology 2007, 5:12 http://www.rbej.com/content/5/1/12
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difference in follicular diameter. However, the time
needed to reach maximal diameter in the Sema-4D treated
group was significantly shorter.
In this study we could not examine endothelial cell-for-
mation, however one can speculate that the growing folli-
cle require induction of angiogenesis together with
growth and remodeling of new blood vessels from a pre-
existing vascular network, to ensure the delivery of oxy-
gen, nutrients, and growth factors, similar to tumor
growth [7]. It is also well documented that Sema-4D,
along with its receptor, Plexin-B1, participate in tumor
growth and proliferation [16]. Semaphorins, such as
Sema-4D, can generate local membrane signals that more
finely regulate cell motility [9]. Moreover, through their
action on cytoskeleton, Semaphorins can induce cytoskel-
etal re-arrangements only in those portions of the target
cells facing surrounding cells expressing plexin on their
membranes. This could allow a finer tuning of directional
movements [17]. Moreover, interaction between these
two families of receptors unveils a new mechanism that
could play a role in the process of follicular growth [18].
In the control group, after the addition of hCG to the cul-
ture, follicular diameter was reduced. This could be
explained by rapid follicular rupture which mimics the
follicular rupture that occurs following ovulation (i.e.
granulosa collapse into the lumen). It is known that the
addition of hCG causes a change in the follicular phase
from growing phase into differentiating phase by causing
granulosa cell luteinization [19]. At this stage granulosa
cells lose their proliferating capacity. The addition of neu-
tralizing antibodies against Plexin-B1 to the Sema-4D
treated group abolished this stimulatory effect on follicu-
lar growth. These antibodies are directed against the lig-
and-binding domain on the receptor, inhibiting Plexin-B1
activity by competing with Sema-4D, the natural ligand.
This finding further supports our hypothesis that Sema-
phorin 4D acts via its receptor, plexin B1.
In our previous study we have shown that the addition of
neutralizing antibodies against Plexin-B1 causes a signifi-
cant reduction in follicular growth. In the present study,
the addition of Sema-4D increased steroid hormone
secretion rate when compared with the control group, and
neutralizing antibodies against Plexin-B1 abolished this
effect. Both estrogen and progesterone secretion patterns
were different between the control and the Sema-4D
treated groups. While estradiol constantly increased, and
remained high in the control group, in the Sema-4D
group estradiol level reached its peak and was subse-
quently reduced to a lower secretion level. The reverse pat-
tern was observed in progesterone secretion. In the
control group, one day after hCG injection, a reduction in
progesterone secretion was demonstrated, while in the
Sema-4D treated group progesterone secretion rate
reached its peak only three days after the addition of hCG.
The signaling pathways mediated by the Plexin/Sema-
phorin system have not been fully elucidated. We cannot
exclude the possibility that changes in cytoskeleton re-
organization influence receptor expression, or that stimu-
lating the Plexin/Semaphorin-cascade influences down
stream cytoplasmic signals involved in steroidogenesis. It
has been reported that the cytoplasmic domain of plexin-
B1 associates with the activated form of the small GTPase
R-Ras, and promotes its inactivation through an intrinsic
R-Ras-GAP activity [20]. Binding of Semaphorin to Plexin
initiates a signaling cascade, which varies depending on
the Plexin/Semaphorin/family pair. The down stream cas-
cade involves the activation of MAPK, which is also
known to be involved in steroidogenesis. It should be
stressed that since Sema-4D already exists in the develop-
ing follicle, one cannot exclude the possibility that the
addition of Sema-4D creates a supra-physiologic effect.
Nevertheless, these results suggest that Sema-4D modu-
lates follicular development rates. The mechanism by
which Sema-4D/Plexin-B1 system affects follicular growth
and steroidogenesis demands clarification.
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